Fred Hutchinson Cancer Research Center, UW Medicine, Seattle Cancer Care Alliance and Seattle Children’s today…
kchenJuly 16, 2021
Imagine you’re in your high school math class waiting to hear back about your college…
kchenJuly 15, 2021
Kineta Announces First Participant Dosed in Phase 1 Multiple Ascending Dose Clinical Trial of KCP506
Kineta Inc, through its subsidiary Kineta Chronic Pain LLC, announced today that the first participant…
kchenJuly 15, 2021
Shigeru Kinoshita, MD, PhD, has joined the medical advisory board at Aurion Biotech, whose mission is…
kchenJuly 15, 2021
In a report first published on the preprint server bioRxiv on June 22, Fred Hutchinson Cancer Research…
kchenJuly 14, 2021
The functional consequences of genetic variants within 5’ untranslated regions (UTRs) on a genome-wide scale…
kchenJuly 14, 2021
Seagen Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D.,…
kchenJuly 13, 2021
An innovative clinical trial led by Dr. Nicholas Vitanza, a neuro-oncologist at Seattle Children’s, shows…
kchenJuly 13, 2021
A novel variant of concern (VOC) named CAL.20C (B.1.427/B.1.429), originally detected in California, carries spike…
kchenJuly 12, 2021
